EURAZEO COMPLETES THE SALE OF ALBINGIA TO A CONSORTIUM LED BY LA FINANCIERE DE BLACAILLOUX (“FIBLAC”)

Eurazeo, through its Mid-large buyout strategy^[1], has completed the disposal of Albingia, independent player in the French commercial insurance lines market, to a consortium led by La financière de Blacailloux (“Fiblac”), the financial holding of the Chamoin family. Fiblac leads a consortium composed of the management team, as well as Krefeld, the family office of the Hermès families, and Fairfax Financial Holdings, a Canadian company specialising in insurance and re-insurance.

With this sale, Eurazeo’s Mid-large buyout exemplifies its strategy of selecting and supporting leading mid-market companies with solid fundamentals and a distinct positioning in high-growth sectors like Tech-Enables Business Services, Financial Services, and Healthcare & Life Sciences.

The transaction has generated a gross cash-on-cash of 2.2x^[2] on Eurazeo’s initial investment with around €325 million of proceeds being allocated to Eurazeo’s balance sheet. .

Footnotes

1. ^{^} Part of Eurazeo Global Investor company.
2. ^{^} Including dividends already received.